Mutant and wild-type α-synuclein interact with mitochondrial cytochrome C oxidase

Journal of Molecular Neuroscience

Volumn 18, Issue 3, 2002, Pages 229-238

  Elkon, Hanock ^a,b   Don, Jermy ^c   Melamed, Eldad ^a,b   Ziv, Ilan ^a,b   Shirvan, Anat ^a,b   Offen, Daniel ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

Coimmunoprecipitation; Cytochrome c oxidase; In vitro translation; Parkinson's disease; Potassium cyanide; Two hybrid system; synuclein

Indexed keywords

ALPHA SYNUCLEIN; COMPLEMENTARY DNA; CYTOCHROME C OXIDASE; MUTANT PROTEIN; POTASSIUM CYANIDE; DOPAMINE; ENZYME INHIBITOR; MYC PROTEIN; NERVE PROTEIN; SNCA PROTEIN, HUMAN; SYNUCLEIN;

ARTICLE; CELL DEATH; GENE MUTATION; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; ONCOGENE C MYC; PARKINSON DISEASE; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; WILD TYPE; ADULT; CELL CULTURE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; TWO HYBRID SYSTEM;

ADULT; BASE SEQUENCE; CYTOCHROME-C OXIDASE; DOPAMINE; ENZYME INHIBITORS; HUMAN; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MUTATION; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POTASSIUM CYANIDE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES; ALPHA-SYNUCLEIN; ELECTRON TRANSPORT COMPLEX IV; HUMANS; SYNUCLEINS;

ORYCTOLAGUS CUNICULUS;

EID: 0036014117     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:18:3:229     Document Type: Article

References (58)

1. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
2. Ubiquitin, cellular inclusions and their role in neurodegeneration
3. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
4. The molecular mechanism of dopamine-induced apoptosis: Identification and characterization of genes that mediate dopamine toxicity
5. Degradation of α-synuclein by proteasome
6. Structure/function of oxygen-regulated isoforms in cytochrome c oxidase
7. Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family
8. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
9. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
10. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
11. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes
12. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments
13. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
14. Sequelae of attempted suicide by cyanide ingestion: A case report
15. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection
16. Neuropathology of Parkinson's disease
17. Rat alpha-synuclein interact with tat binding protein 1, a component of the 26S proteasomal complex
18. Clinical and CT scan findings in a case of cyanide intoxication
19. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
20. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease
21. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
22. Alpha-synuclein promote mitochondrial deficit and oxidative stress
23. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
24. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synuclein
25. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain
26. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and c-terminal truncation
27. Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein
28. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
29. Cellular pathology of multiple system atrophy
30. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
31. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
32. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
33. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
34. Both familial PD mutations accelerate α-synuclein aggregation
35. Prevention of dopamine-induced cell death by thiol antioxidants: Possible implications for treatment of Parkinson's disease
36. Dopamine-melanin induces apoptosis in PC12 cells: Possible implications for the etiology of Parkinson's disease
37. Alpha-Synuclein shares physical and functional homology with 14-3-3 proteins
38. Mutation in the α-Synuclein gene identified in families with Parkinson's Disease
39. Cyanide-induced parkinsonism: Clinical, MRI, and 6-fluorodopa PET studies
40. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40
41. Mitochondrial complex I deficiency in Parkinson's disease
42. Mitochondria in the etiology and pathogenesis of Parkinson's disease
43. Glutathione-related enzymes in brain in Parkinson's disease
44. Dopamine-induced apoptosis in human neuronal cells: Inhibition by nucleic acids antisense to the dopamine transporter
45. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
46. Alpha-synuclein in Lewy bodies
47. Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
48. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
49. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines
50. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
51. Alpha-synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro
52. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
53. Cyanide-induced parkinsonism: A clinico-pathologic report
54. Neuropathology in mice expressing human alpha-synuclein
55. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
56. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
57. Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease?
58. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - A possible novel pathogenetic mechanism in Parkinson's disease